Sanofi SA vs Symbotic Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Symbotic Inc trades at $43.06 (market cap $5.19B). The key difference: Sanofi SA is far larger — about 20.2× Symbotic Inc's market cap, and Sanofi SA pays a 5.5% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| SNY | SYM | |
|---|---|---|
Market Cap | $104.83B | $5.19B |
Sector | Health | Technology |
52-Week High | $52.34 | $87.30 |
52-Week Low | $41.33 | $38.57 |
Enterprise Value | $121.32B | $3.18B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →